The Efficacy of Mirodenafil for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Middle Aged Patients

Trial Profile

The Efficacy of Mirodenafil for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Middle Aged Patients

Not stated
Phase of Trial: Phase II

Latest Information Update: 15 Apr 2014

At a glance

  • Drugs Mirodenafil (Primary) ; Levofloxacin
  • Indications Bacterial infections; Pelvic pain; Prostatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.
    • 09 May 2013 New trial record
    • 06 May 2013 Results presented at the 108th Annual Meeting of the American Urological Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top